INVO Fertility (IVF) Interest & Investment Income (2021 - 2022)
INVO Fertility (IVF) reported Interest & Investment Income of $1.0 for Q4 2022, down 98.39% year-over-year from $62.0 in Q4 2021, and down 97.06% on a QoQ basis from $34.0 in Q3 2022.
INVO Fertility (IVF) has 2 years of Interest & Investment Income data on file, last reported at $1.0 in Q4 2022.
- Quarterly Interest & Investment Income fell 98.39% year-over-year to $1.0 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $308.0 (down 91.58% YoY) and the FY2022 annual result came in at $308.0, down 91.58% from the prior year.
- Interest & Investment Income fell to $1.0 in Q4 2022 per IVF's latest filing, from $34.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $2425.0 in Q2 2021 and bottomed at -$843.0 in Q3 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 106.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 33.50 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -25.76 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | INVO Fertility | 5.12 Mn | 4.76 Mn | 629,345.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 1.00 |
| Sep 30, 2022 | 34.00 |
| Jun 30, 2022 | 48.00 |
| Mar 31, 2022 | 225.00 |
| Dec 31, 2021 | 62.00 |
| Sep 30, 2021 | -843.00 |
| Jun 30, 2021 | 2,425.00 |
| Mar 31, 2021 | 2,013.00 |